Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MR Value: Clinical Feasibility of Abbreviated MR Protocol for HCC Surveillance in High-risk Group

NCT03731923 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT03731923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03731923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MR Value: Clinical Feasibility of Abbreviated MR Protocol for HCC Surveillance in High-risk Group
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
November 8, 2018
Completion date
December 31, 2023
Enrollment
257 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis, hepatocellular carcinoma, liver cirrhosis